Cytokinetics Inc. (CYTK) Cut to "Hold" at Zacks Investment Research

Cytokinetics Inc. (CYTK) Cut to "Hold" at Zacks Investment Research


According to Zacks, "Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility.



from Biotech News